| 1 | 3I8V |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens |
P27815 (PDE4A_HUMAN) |
(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one |
0MO |
 |
SHOW |
| 2 | 1OYN |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens |
Q08499 (PDE4D_HUMAN) |
ROLIPRAM |
ROL |
 |
SHOW |
| 3 | 1ZKN |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens |
Q08499 (PDE4D_HUMAN) |
3-ISOBUTYL-1-METHYLXANTHINE |
IBM |
 |
SHOW |
| 4 | 3K4S |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens |
Q08499 (PDE4D_HUMAN) |
(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one |
0MO |
|
SHOW |
| 5 | 6KPG |
Cannabinoid receptor 1 | Homo sapiens |
P21554 (CNR1_HUMAN) |
(6~{a}~{R},9~{R},10~{a}~{R})-9-(hydroxymethyl)-3-(8-isothiocyanato-2-methyl-octan-2-yl)-6,6-dimethyl-6~{a},7,8,9,10,10~{a}-hexahydrobenzo[c]chromen-1-ol |
8D0 |
 |
SHOW |
| 6 | 6KPC |
Cannabinoid receptor 1 | Homo sapiens |
P21554 (CNR1_HUMAN) |
(6~{a}~{R},9~{R},10~{a}~{R})-9-(hydroxymethyl)-3-(8-isothiocyanato-2-methyl-octan-2-yl)-6,6-dimethyl-6~{a},7,8,9,10,10~{a}-hexahydrobenzo[c]chromen-1-ol |
8D0 |
|
SHOW |
| 7 | 6PT0 |
Cannabinoid receptor 2 | Homo sapiens |
P34972 (CNR2_HUMAN) |
{(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone |
WI5 |
 |
SHOW |
| 8 | 6KPF |
Cannabinoid receptor 2 | Homo sapiens |
P34972 (CNR2_HUMAN) |
(6~{a}~{R},9~{R},10~{a}~{R})-9-(hydroxymethyl)-3-(8-isothiocyanato-2-methyl-octan-2-yl)-6,6-dimethyl-6~{a},7,8,9,10,10~{a}-hexahydrobenzo[c]chromen-1-ol |
8D0 |
|
SHOW |
| 9 | 6J10 |
Capsid protein | Hepatitis B virus genotype D subtype adw |
P03147 (CAPSD_HBVD1) |
6-cyclohexyl-4-methyl-1-oxidanyl-pyridin-2-one |
B4O |
 |
SHOW |
| 10 | 4DCG |
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase | Vaccinia virus |
P07617 (MCE_VACCW) |
7-METHYLGUANOSINE |
MG7 |
 |
SHOW |
| 11 | 1JSZ |
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase | Vaccinia virus |
P07617 (MCE_VACCW) |
7,9-DIMETHYLGUANINE |
NDM |
 |
SHOW |
| 12 | 3MAG |
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase | Vaccinia virus |
P07617 (MCE_VACCW) |
6-AMINO-3-METHYLPURINE |
3MA |
 |
SHOW |
| 13 | 1BKY |
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase | Vaccinia virus |
P07617 (MCE_VACCW) |
1-METHYLCYTOSINE |
1MC |
 |
SHOW |
| 14 | 1EQA |
Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase | Vaccinia virus |
P07617 (MCE_VACCW) |
7-METHYLGUANOSINE |
MG7 |
|
SHOW |
| 15 | 6RT8 |
Catharanthine synthase | Catharanthus roseus |
A0A2P1GIW2 (CS_CATRO) |
18-carboxymethoxy-cleaviminium |
KJE |
 |
SHOW |
| 16 | 3UPE |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
1-[(7-carbamimidoylnaphthalen-2-yl)methyl]-6-({1-[(1Z)-ethanimidoyl]piperidin-4-yl}oxy)-2-(propan-2-yl)-1H-indole-4-carboxylic acid |
0CA |
 |
SHOW |
| 17 | 1Y59 |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
2,5-BIS-O-{3-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL |
TL1 |
 |
SHOW |
| 18 | 1Y5A |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
2-O-{4-[AMINO(IMINO)METHYL]PHENYL}-5-O-{3-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL |
TL2 |
 |
SHOW |
| 19 | 1Y5U |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
2-O-{3-[AMINO(IMINO)METHYL]PHENYL}-5-O-{4-[AMINO(IMINO)METHYL]PHENYL}-1,4:3,6-DIANHYDRO-D-GLUCITOL |
TL4 |
 |
SHOW |
| 20 | 1V2K |
Cationic trypsin | Bos taurus |
P00760 (TRY1_BOVIN) |
[4-(6-CHLORO-NAPHTHALENE-2-SULFONYL)-PIPERAZIN-1-YL]- (3,4,5,6-TETRAHYDRO-2H-[1,4']BIPYRIDINYL-4-YL)- METHANONE |
ZEN |
 |
SHOW |
| 21 | 5T1A |
C-C chemokine receptor type 2 | Homo sapiens |
P41597 (CCR2_HUMAN) |
(3S)-1-{(1S,2R,4R)-4-[methyl(propan-2-yl)amino]-2-propylcyclohexyl}-3-{[6-(trifluoromethyl)quinazolin-4-yl]amino}pyrrolidin-2-one |
73R |
 |
SHOW |
| 22 | 6AKX |
C-C chemokine receptor type 5 | Homo sapiens |
P51681 (CCR5_HUMAN) |
N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-(thiophen-2-yl)propyl]cyclopentanecarboxamide |
A4R |
 |
SHOW |
| 23 | 4MBS |
C-C chemokine receptor type 5 | Homo sapiens |
P51681 (CCR5_HUMAN) |
4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl}-1-phenylpropyl]cyclohexanecarboxamide |
MRV |
 |
SHOW |
| 24 | 6AKY |
C-C chemokine receptor type 5 | Homo sapiens |
P51681 (CCR5_HUMAN) |
4,4-difluoro-N-[(1S)-3-{(3-exo)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl}-1-(thiophen-3-yl)propyl]cyclohexane-1-carboxamide |
A4X |
 |
SHOW |
| 25 | 6R13 |
Cereblon isoform 4 | Magnetospirillum gryphiswaldense |
A4TVL0 (A4TVL0_9PROT) |
~{N}-[(3~{S})-2,5-bis(oxidanylidene)pyrrolidin-3-yl]-3-phenyl-propanamide |
JOK |
 |
SHOW |